Daily Newsletter

23 November 2023

Daily Newsletter

23 November 2023

Hospital in Your Home opens flagship clinic in Georgia

The new clinic is said to serve as a hub to bring quality, patient-centric care to underserved populations.

November 22 2023

Hospital in Your Home (HiYH) has launched its flagship clinic in downtown College Park, Georgia, aiming to address healthcare disparities in the community.

This new clinic is said to serve as a hub to bring quality, patient-centric care to underserved populations.

Besides, the healthcare provider has announced the launch of two programmes, including Virtual Care and NovellaCare.

Virtual Care programme connects patients with healthcare professionals from home, especially benefiting seniors and the homebound.

NovellaCare programme focuses on comprehensive chronic disease management and personalised care.

HiYH US co-founder Dr. Michael Young said: “This launch aligns perfectly with our mission to redefine healthcare delivery.

“We believe that everyone should have access to quality healthcare, and our model is designed to achieve just that.

“Our approach not only improves patient outcomes but also reduces the overall cost of care, which is a win-win for patients and the community.”

HiYH invites community engagement, encouraging residents to enrol in its programmes and is seeking partnerships with local hospitals to expand its services and offer hospital-level acute care in patients' homes.

HiYH provides care through Virtual Care, NovellaCare, community involvement, and strategic collaborations.

According to the health system’s website, HIYH service offers care in the patient's own home or chosen location as an alternative to hospitalisation.

The service, organised for an agreed period, supports recovery, and patients remain under the care of the hospital during this time.

A team of health professionals, experienced in acute care, manages the transition from hospital to home, creating a tailored treatment plan in collaboration with the patient.

They offer service is for public patients and is free of charge.

Common treatments include intravenous antibiotic therapy, fluid rehydration, and administration of short-term injectable medications.

Is it time for the healthcare sector to fully embrace the benefits of digitalization and AI?

Only a handful of approved therapeutic drugs are currently available for the treatment of ARF, all belonging to the solute carrier family 12 member 1 inhibitor. The clinical trial space in ARF consists of almost an equal mix of commercial as well as academic sponsors, with Iran and the US emerging as the key countries for conducting Phase III trials. While the current marketed drug space for ARF has only a handful of treatment options, currently available mid-to-late-stage pipeline drugs are likely to pave the way for a new treatment approach in the future.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close